tweetindex
IT

Mohamad Mohty ✓

@Mohty_EBMT · joined 20 Jun 2014

Professor of Hematology; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.

23 888Followers
2 945Following
38 174Posts total
19KViews on collected posts

Ultimi post

@Mohty_EBMT @TheIACH Congratulations! This is a vital review. The mechanistic story behind CELMoDs is clear, and this will help clinicians think through sequencing better. 👏👏 51 views · 1 likes · 0 reposts · 0 replies Open on X →
@Mohty_EBMT @TheIACH I see a future without IMiDS/CELMODS, and only short duration steroids. Feasible? 105 views · 0 likes · 0 reposts · 0 replies Open on X →
@Mohty_EBMT @scserendipity1 @TheIACH Congratulations @Mohty_EBMT 134 views · 2 likes · 0 reposts · 0 replies Open on X →
Few drug classes have transformed multiple myeloma as profoundly as IMiDs. Proud to share our latest review in the J Clin Oncol. From thalidomide to lenalidomide and pomalidomide, and now to next-generation cereblon E3 ligase modulators (CELMoDs). @TheIACH https://t.co/u4eglIeqXZ
10.3K views · 56 likes · 20 reposts · 4 replies Open on X →
In tribute to the late Dr R Kyle, @TheIACH will rebroadcast his “Standing on the Shoulders of Giants” webinar, celebrating his extraordinary legacy and lifelong contributions to hematology. We invite the community to join us in honoring a true pioneer. https://t.co/s9XPhkMVKI 2.1K views · 29 likes · 11 reposts · 2 replies Open on X →
@Mohty_EBMT 👏👏 12 views · 1 likes · 0 reposts · 0 replies Open on X →
In tribute to the late Dr R Kyle, IACH will rebroadcast his “Standing on the Shoulders of Giants” webinar, celebrating his extraordinary legacy and lifelong contributions to hematology. We invite the community to join us in honoring a true pioneer. https://t.co/s9XPhkMVKI 1.7K views · 22 likes · 14 reposts · 0 replies Open on X →
RIP Bob https://t.co/2hZuCACZUv
1.7K views · 39 likes · 6 reposts · 1 replies Open on X →
@Mohty_EBMT A great read, @Mohty_EBMT . RIP to the legend 81 views · 3 likes · 0 reposts · 0 replies Open on X →
My interview in 2023 with Dr Kyle. RIP Bob. https://t.co/q2lNWXWgA5 https://t.co/TUN7lOTwWJ
2.8K views · 45 likes · 14 reposts · 2 replies Open on X →

Rispetto ad account della stessa dimensione

10 post degli ultimi 90 giorni, accanto alla fascia di 10K–100K follower. copertura nella norma per la sua dimensione, reazione più forte della media.

Visualizzazioni mediane917questo account924mediana per 10K–100K
Copertura, %3.84%questo account3.62%mediana per 10K–100K
Interazione, %2.08%questo account1.52%mediana per 10K–100K
MetricaQuesto accountMediana per 10K–100KRapporto
Visualizzazioni mediane per post9179240.99×
Copertura (visualizzazioni ÷ follower)3.84%3.62%1.06×
Tasso di interazione2.08%1.52%1.37×

Altri account di questa fascia →   Confronta con un altro account →   Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.8K4 Sep
81
1.7K5 Sep
1.7K6 Sep
12
2.1K9 Sep
10.3K12 Sep
134
105
5113 Sep

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

2.18%4 Sep
3.70%
2.75%5 Sep
2.12%6 Sep
8.33%
2.04%9 Sep
0.81%12 Sep
1.49%
0.00%
1.96%13 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes64.9%198 in total
Reposts21.3%65 in total
Replies3.0%9 in total
Quotes1.6%5 in total
Bookmarks9.2%28 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Account simili